Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesBudesonide Is Effective in Treating Lymphocytic Colitis: A Randomized Double-Blind Placebo-Controlled Study
Gastroenterology, 06/10/09
Miehlke S et al. - Budesonide effectively induces clinical remission in patients with lymphocytic colitis and significantly improves histology results after 6 weeks. Clinical relapses occur but can be treated again with budesonide.
Related Articles
Lymphocytic enterocolitis in systemic lupus erythematosus
Saudi Journal of Gastroenterology, 10/05/09
Relevance Score: 64%
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Relevance Score: 46%
AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations
Modern Pathology, 11/11/09
Relevance Score: 45%
Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09
Relevance Score: 45%
Microscopic colitis: a review for the surgical endoscopist
Canadian Journal of Surgery, 10/16/09
Relevance Score: 44%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Toxicities of Gemcitabine in Patients with Severe Hepatic Dysfunction
Annals of Pharmacotherapy, 03/17/10
CYP3A4 catalytic activity is induced in confluent Huh7 hepatoma cells
Drug Metabolism and Disposition, 03/17/10
A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues
Drug Metabolism and Disposition, 03/17/10
Article Search
Sponsor
Sponsor